Why Long-Acting Injectables?
Details
🚨 REGISTRATION REQUIRED: Clicking "Going" on Meetup does not reserve your ticket. You must formally register and complete payment on our website to secure your spot: https://www.aaps-badg.org/event-registration
Join AAPS-BADG for an evening uncovering the latest breakthroughs in long-acting drug delivery and formulation science!
SPEAKERS:
Dr. Mamoun Alhamadsheh
(UOP Professor & Eidos Therapeutics Co-Founder)
"A Novel Transthyretin-Coupled Zwitterionic Depots for Long-Acting Injectables" Renowned for discovering acoramidis for transthyretin cardiac amyloidosis, Dr. Alhamadsheh's lab focuses on extending drug half-life and improving delivery.
Dr. William Rowe & Dr. David Stern (Gilead Sciences Formulation Scientists)
"Developing Long-Acting Treatments Through Molecule Design and Formulation" With PhDs from MIT and Johns Hopkins, they bring deep expertise in small molecule formulation for long-acting HIV therapies.
DATE & AGENDA:
🗓️ Wednesday, June 10, 2026
• 5:00 PM: Networking reception (food & drinks provided)
• 5:45 PM: Dr. Alhamadsheh 's talk + Q&A
• 6:30 PM: Dr. Rowe & Dr. Stern talk + Q&A
• 7:15 PM: Extended networking
WHO SHOULD ATTEND:
Industry professionals, academics, students, and entrepreneurs interested in pharmaceutical science, drug delivery, formulation science, or biotech innovation. Science enthusiasts are all welcome!
COST:
$10 regular | $5 students, unemployed, retired
LOCATION:
Genentech, 601 Gateway Blvd. 1st Floor,
South San Francisco, CA 94080
Parking available.
About BADG:
Bay Area Discussion Group is the local chapter of the American Association of Pharmaceutical Scientists (AAPS). Our mission is to connect pharmaceutical scientists throughout the San Francisco Bay Area through seminars, workshops, and networking events.
Website:
www.aaps-badg.org